DuoGenic StemCells (ROCO:7607) Net Margin % : -634.25% (As of Jun. 2024)

View and export this data going back to 2023. Start your Free Trial

What is DuoGenic StemCells Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. DuoGenic StemCells's Net Income for the six months ended in Jun. 2024 was NT$-32.30 Mil. DuoGenic StemCells's Revenue for the six months ended in Jun. 2024 was NT$5.09 Mil. Therefore, DuoGenic StemCells's net margin for the quarter that ended in Jun. 2024 was -634.25%.

The historical rank and industry rank for DuoGenic StemCells's Net Margin % or its related term are showing as below:

ROCO:7607' s Net Margin % Range Over the Past 10 Years
Min: -956.9 Med: -496.21 Max: -330.99
Current: -485.18

ROCO:7607's Net Margin % is ranked worse than
67.7% of 1003 companies
in the Biotechnology industry
Industry Median: -127.31 vs ROCO:7607: -485.18

DuoGenic StemCells Net Margin % Historical Data

The historical data trend for DuoGenic StemCells's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DuoGenic StemCells Net Margin % Chart

DuoGenic StemCells Annual Data

Trend

Dec21

Dec22

Dec23

Net Margin %

-956.90

-496.21

-330.99

DuoGenic StemCells Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Net Margin %	Get a 7-Day Free Trial			-631.09	-428.65	-300.66	-365.83	-634.25

Competitive Comparison of DuoGenic StemCells's Net Margin %

For the Biotechnology subindustry, DuoGenic StemCells's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DuoGenic StemCells's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, DuoGenic StemCells's Net Margin % distribution charts can be found below:

* The bar in red indicates where DuoGenic StemCells's Net Margin % falls into.

Save Embed

;

Save Embed

;

DuoGenic StemCells Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

DuoGenic StemCells's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-45.236	/	13.667
	=	-330.99 %

DuoGenic StemCells's Net Margin for the quarter that ended in Jun. 2024 is calculated as

Net Margin	=	Net Income (Q: Jun. 2024 )	/	Revenue (Q: Jun. 2024 )
	=	-32.296	/	5.092
	=	-634.25 %

DuoGenic StemCells (ROCO:7607) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

DuoGenic StemCells Net Margin % Related Terms

Thank you for viewing the detailed overview of DuoGenic StemCells's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

DuoGenic StemCells Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DuoGenic StemCells Corp (ROCO:7607) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Room R207, Innovation Incubation Center, 145, Xingda Road, South District, Taichung, TWN

Website

https://www.dgsc.com.tw

DuoGenic StemCells Corp is a company having a team of passionate researchers focused on stem cell cultivation. Their products are intended for research use and can be upgraded for clinical applications. It also develops blood cell therapy programs, using the isolation and purification of blood mononuclear cells to remove granule cells that promote inflammation, and conducts clinical trials on various degenerative diseases to provide a convenient and simple new option for cell therapy.

DuoGenic StemCells Headlines

No Headlines